2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1528003043 M.D.
Verify on CMS →

DMITRY GREBENEV, M.D.

Endocrinology, Diabetes & Metabolism Physician in LARGO, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 494 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.85/100
▲ 1 pts above national avg 83.1 · [object Object]
Industry payments
$622.06
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DMITRY GREBENEV, M.D. reported a CMS MIPS final score of 83.85/100 — above the 83.1 national average — and filed 3,466 Medicare Part D claims in 2023.

83.85/100
MIPS score · +1 vs avg
3K
Part D claims, 2023
48%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DMITRY GREBENEV, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

84 42nd percentile higher than 42% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DMITRY GREBENEV, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DMITRY GREBENEV, M.D.?

Near national average

NPI registry status

Active

Issued 06/18/2006

NPI 1528003043

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

3,466 31% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

83.85/100 0.75% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

DMITRY GREBENEV, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
83.85/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 83.85/100 vs national avg 83.1

0%100%National avg83%83.9%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 83.85/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DMITRY GREBENEV, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 13117 66TH ST, LARGO, FL, 33773, with a listed phone of (727) 516-8482. NPI 1528003043 was issued on 06/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GREBENEV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,466 prescription claims written by this provider, covering 494 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.85/100 for the 2023 performance year, compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13117 66TH ST
LARGO, FL 33773

Provider Details

NPI 1528003043
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 06/18/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

83.85
Final Score
Avg: 83.1
81
Promoting Interoperability

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DMITRY GREBENEV, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$622

Largest payer

Medtronic, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to DMITRY GREBENEV, M.D.. To verify DMITRY GREBENEV, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

DMITRY GREBENEV, M.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 3,466 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,466
Total Claims
$1.9M
Total Drug Cost
494
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,847
Total Day Supply
263,193
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$1.8M
Generic Drug Cost
$58K

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.71
Gender Split
55% female / 45% male
Age Distribution
<65: 49, 65-74: 265, 75-84: 144, 85+: 36

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DMITRY GREBENEV, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
483
Glimepiride
194
Metformin Hcl
136
Synthroid
Levothyroxine Sodium
121
Tresiba Flextouch U-200
Insulin Degludec
115
Metformin Hcl Er
Metformin Hcl
105
Testosterone Cypionate
102
Atorvastatin Calcium
87
Ozempic
Semaglutide
80
Rosuvastatin Calcium
79

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How DMITRY GREBENEV, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

DMITRY GREBENEV, M.D.'s 3,466 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GREBENEV.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DMITRY GREBENEV, M.D.'s specialty?
DMITRY GREBENEV, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in LARGO, Florida. Credentials: M.D..
How much does DMITRY GREBENEV, M.D. prescribe under Medicare Part D?
In 2023, DMITRY GREBENEV, M.D. wrote 3,466 Medicare Part D claims totaling $1.9M in drug costs for 494 beneficiaries.
What is DMITRY GREBENEV, M.D.'s Medicare quality score?
DMITRY GREBENEV, M.D. has a CMS MIPS Final Score of 83.85/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DMITRY GREBENEV, M.D. located?
DMITRY GREBENEV, M.D. is located at 13117 66TH ST, LARGO, FL, 33773. Phone: (727) 516-8482.
What is DMITRY GREBENEV, M.D.'s NPI number?
DMITRY GREBENEV, M.D.'s National Provider Identifier (NPI) is 1528003043, issued on 06/18/2006.
Does DMITRY GREBENEV, M.D. prescribe more brand-name or generic drugs?
DMITRY GREBENEV, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $1.8M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does DMITRY GREBENEV, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DMITRY GREBENEV, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Glimepiride, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DMITRY GREBENEV, M.D. accept Medicare?
DMITRY GREBENEV, M.D. appears in CMS Medicare data with 3,466 Part D claims and 494 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DMITRY GREBENEV, M.D.'s credentials?
DMITRY GREBENEV, M.D.'s NPI is 1528003043 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology